48-HOUR REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

markets.businessinsider.com · 2026-09-12

San Diego, California--(Newsfile Corp. - September 12, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rege...